Pharma R&D center stage as Japan preps For new agency
This article was originally published in Scrip
Executive Summary
Japan's government is gearing up for major changes in how it funds basic pharma and medtech R&D, with a new agency due to be set up next March as part of a broader healthcare policy initiative approved earlier this year.